BDNF, brain derived neurotrophic factor, 627

N. diseases: 992; N. variants: 56
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE In adulthood, BDNF can modulate neuronal synaptic strength and has been implicated in hippocampal mechanisms of learning and memory and spinal mechanisms for pain. 15469390 2004
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE In this study, sections of both chronic painful (tendinosis) and pain-free (non-tendinosis) human Achilles tendons were immunohistochemically stained with antibodies against the neurotrophins NGF and BDNF, and their receptors TrkA, TrkB and p75. 19475530 2009
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype RGD Behavioral testing and immunohistochemical and mRNA analysis of the DRG were performed to determine BDNF's role in pain modulation. 20452292 2010
CUI: C0030193
Disease: Pain
Pain
0.300 GeneticVariation phenotype BEFREE In the presence of chronic pain, the COMT Met allele and the BDNF Met allele augmented cortical pain processing, whilst reducing pain processing in pain-free controls. 21049025 2010
CUI: C0030193
Disease: Pain
Pain
0.300 GeneticVariation phenotype BEFREE BDNF Val66Met polymorphism affects the tPREP N2-P2 amplitude decrement and influences cortical pain processing through neurotrophin-induced neural plasticity, or through a direct BDNF neurotransmitter-like effect. 22901763 2012
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Recent evidence implicates brain-derived neurotrophic factor (BDNF) in visceral hypersensitivity and pain in functional gastrointestinal disorders. 23020799 2013
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE The neurotrophin nerve growth factor (NGF), by binding to tropomyosin receptor A (TrkA) and p75NTR receptors, is essential for the development and survival of sensory neurons, and for pain perception during adulthood. 24494679 2014
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Our genetic findings related to pain expand prior reports related to BDNF and NTRK2. 27283266 2016
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Peripheral Brain Derived Neurotrophic Factor Precursor Regulates Pain as an Inflammatory Mediator. 27251195 2016
CUI: C0030193
Disease: Pain
Pain
0.300 GeneticVariation phenotype BEFREE Our findings indicate that the BDNF Val66Met polymorphism is associated with the diverse functional expressions of the descending pain modulatory systems. 27010666 2016
CUI: C0030193
Disease: Pain
Pain
0.300 AlteredExpression phenotype BEFREE Subgroup comparisons suggest that use of pain-relief drugs may influence BDNF levels. 28376368 2017
CUI: C0030193
Disease: Pain
Pain
0.300 AlteredExpression phenotype BEFREE This is also consistent with a significant correlation between breakthrough pain, measured by pain questionnaire, and combined high serum levels of BDNF and IL6 in patients with BM, and also by immunofluorescence staining showing IL8 expression that was more in mesenchymal stromal cells rather than in tumors cells, and close to LAMP-2 positive acidifying carcinoma cells in BM tissue sections. 28903357 2017
CUI: C0030193
Disease: Pain
Pain
0.300 AlteredExpression phenotype BEFREE Naltrexone and/or sucrose prevented neonatal pain induced impairment of long-term memory, while neonatal pain decreased levels of BDNF in the hippocampus; this decrease was averted by sucrose and naltrexone. 28663110 2017
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE BDNF infusion into bilateral infralimbic cortices to activate neuronal activities could alleviate inflammatory pain and accelerate long-term recovery from pain. 28648456 2017
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Collectively, these results suggest that Fyn kinase-mediated pGluN2B<sup>Y1472</sup> is critical for BDNF-induced spinal LTP and pain hypersensitivity in SNL rats. 28497343 2017
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Therefore, this FM animal model might be useful for investigating mechanisms linking BDNF-CREB pathway and pain. 28706449 2017
CUI: C0030193
Disease: Pain
Pain
0.300 GeneticVariation phenotype BEFREE The Val66Met brain-derived neurotrophic factor gene variant interacts with early pain exposure to predict cortisol dysregulation in 7-year-old children born very preterm: Implications for cognition. 26318333 2017
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Contribution of BDNF/TrkB signalling in the rACC to the development of pain-related aversion via activation of ERK in rats with spared nerve injury. 28732667 2017
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Targeting brain-derived neurotrophic factor in the medial thalamus for the treatment of central poststroke pain in a rodent model. 28394853 2017
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Moreover, we reported that WTD rescued the mal-regulated BDNF and TNF-α in hippocampal CA3 alone, which is proven contributing to the pain and induced psychiatric symptoms. 28931876 2017
CUI: C0030193
Disease: Pain
Pain
0.300 GeneticVariation phenotype BEFREE Our results suggest that pain experience preponderantly affects the effect of <i>BDNF</i> Val66Met polymorphism on brain complexity. 30524221 2018
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Dexmedetomidine (DEX) could have an analgesic effect on pain transmission through the modulation of brain-derived neurotrophic factor (BDNF). 29872336 2018
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE Paradoxical Sleep Deprivation Aggravates and Prolongs Incision-Induced Pain Hypersensitivity via BDNF Signaling-Mediated Descending Facilitation in Rats. 30324331 2018
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE In addition, blockade of microglial reactivity by intrathecal application of minocycline attenuates the elevation of BDNF and the LTP facilitation, and also, alleviates pain hypersensitivity in nIN-IN rats. 29729892 2018
CUI: C0030193
Disease: Pain
Pain
0.300 Biomarker phenotype BEFREE An important clinical implication of the study is that interference with BDNF and RANTES production, by selectively targeting the JNK and NF-κB cascades, may offer a tractable therapeutic strategy to mitigate the pain and inflammation associated with endometriosis. 30031725 2018